These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11783772)

  • 1. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
    Mora C; Macía ML; García J; Navarro JF
    Perit Dial Int; 2001; 21(6):611-4. PubMed ID: 11783772
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients.
    Teruel JL; Lasuncion MA; Rivera M; Aguilera A; Ortega H; Tato A; Marcen R; Ortuño J
    Am J Kidney Dis; 1997 Apr; 29(4):569-75. PubMed ID: 9100047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
    Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
    J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG; Nordin BE; Chatterton BE
    Osteoporos Int; 1993; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract]   [Full Text] [Related]  

  • 6. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.
    Flicker L; Hopper JL; Larkins RG; Lichtenstein M; Buirski G; Wark JD
    Osteoporos Int; 1997; 7(1):29-35. PubMed ID: 9102059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year.
    Gerritsma EJ; Brocaar MP; Hakkesteegt MM; Birkenhäger JC
    Clin Otolaryngol Allied Sci; 1994 Feb; 19(1):79-84. PubMed ID: 8174308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nandrolone decanoate; use in HIV-associated lipodystrophy syndrome: a pilot study.
    Gold J; Batterham M
    Int J STD AIDS; 1999 Aug; 10(8):558. PubMed ID: 10471109
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients.
    Barton Pai A; Chretien C; Lau AH
    Clin Nephrol; 2002 Jul; 58(1):38-46. PubMed ID: 12141405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.
    Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF
    Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anabolic steroids in the treatment of malnourished CAPD patients: a retrospective study.
    Dombros NV; Digenis GE; Soliman G; Oreopoulos DG
    Perit Dial Int; 1994; 14(4):344-7. PubMed ID: 7827183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis.
    Gascón A; Belvis JJ; Berisa F; Iglesias E; Estopiñán V; Teruel JL
    Geriatr Nephrol Urol; 1999; 9(2):67-72. PubMed ID: 10518249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
    Berns JS; Rudnick MR; Cohen RM
    Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nandrolone decanoate on bone mass in established osteoporosis.
    Passeri M; Pedrazzoni M; Pioli G; Butturini L; Ruys AH; Cortenraad MG
    Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
    Johansen KL; Mulligan K; Schambelan M
    JAMA; 1999 Apr; 281(14):1275-81. PubMed ID: 10208142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M; Saraf ML
    Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the anabolic steroid nandrolone decanoate on plasma lipids and coronary arteries of female cynomolgus macaques.
    Obasanjo IO; Clarkson TB; Weaver DS
    Metabolism; 1996 Apr; 45(4):463-8. PubMed ID: 8609832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era.
    Johansen KL
    Int J Artif Organs; 2001 Apr; 24(4):183-5. PubMed ID: 11394696
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
    Strawford A; Barbieri T; Neese R; Van Loan M; Christiansen M; Hoh R; Sathyan G; Skowronski R; King J; Hellerstein M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):137-46. PubMed ID: 10048900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
    Need AG; Horowitz M; Walker CJ; Chatterton BE; Chapman IC; Nordin BE
    Bone; 1989; 10(1):3-6. PubMed ID: 2736154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.